ID LY75_HUMAN Reviewed; 1722 AA. AC O60449; O75913; Q53R46; Q53TF5; Q7Z575; Q7Z577; DT 19-SEP-2003, integrated into UniProtKB/Swiss-Prot. DT 11-JAN-2011, sequence version 3. DT 02-OCT-2024, entry version 198. DE RecName: Full=Lymphocyte antigen 75; DE Short=Ly-75; DE AltName: Full=C-type lectin domain family 13 member B; DE AltName: Full=DEC-205; DE AltName: Full=gp200-MR6; DE AltName: CD_antigen=CD205; DE Flags: Precursor; GN Name=LY75; Synonyms=CD205, CLEC13B; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606 {ECO:0000312|EMBL:AAC17636.1}; RN [1] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), PARTIAL PROTEIN SEQUENCE, TISSUE RP SPECIFICITY, GLYCOSYLATION, AND VARIANTS ASP-268 AND GLU-807. RC TISSUE=Thymus; RX PubMed=9862343; RX DOI=10.1002/(sici)1521-4141(199812)28:12<4071::aid-immu4071>3.0.co;2-o; RA McKay P.F., Imami N., Johns M., Taylor-Fishwick D.A., Sedibane L.M., RA Totty N.F., Hsuan J.J., Palmer D.B., George A.J.T., Foxwell B.M.J., RA Ritter M.A.; RT "The gp200-MR6 molecule which is functionally associated with the IL-4 RT receptor modulates B cell phenotype and is a novel member of the human RT macrophage mannose receptor family."; RL Eur. J. Immunol. 28:4071-4083(1998). RN [2] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANT ASN-1321. RX PubMed=9553150; DOI=10.1007/s002510050381; RA Kato M., Neil T.K., Clark G.J., Morris C.M., Sorg R.V., Hart D.N.J.; RT "cDNA cloning of human DEC-205, a putative antigen-uptake receptor on RT dendritic cells."; RL Immunogenetics 47:442-450(1998). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), TISSUE SPECIFICITY, AND RP VARIANT ASN-1321. RX PubMed=12824192; DOI=10.1074/jbc.m303112200; RA Kato M., Khan S., Gonzalez N., O'Neill B.P., McDonald K.J., Cooper B.J., RA Angel N.Z., Hart D.N.J.; RT "Hodgkin's lymphoma cell lines express a fusion protein encoded by RT intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) RT and a novel C-type lectin receptor DCL-1."; RL J. Biol. Chem. 278:34035-34041(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-933, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). CC -!- FUNCTION: Acts as an endocytic receptor to direct captured antigens CC from the extracellular space to a specialized antigen-processing CC compartment (By similarity). Causes reduced proliferation of B- CC lymphocytes. {ECO:0000250}. CC -!- INTERACTION: CC O60449-3; Q969F0: FATE1; NbExp=3; IntAct=EBI-10186753, EBI-743099; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I CC membrane protein {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=4; CC IsoId=O60449-1; Sequence=Displayed; CC Name=2; Synonyms=Fusion protein variant V34-2; CC IsoId=O60449-2; Sequence=VSP_020909; CC Name=5; CC IsoId=Q8IX05-2; Sequence=External; CC Name=3; Synonyms=Fusion protein variant V33-2; CC IsoId=O60449-3; Sequence=VSP_020908; CC Name=1; CC IsoId=Q8IX05-1; Sequence=External; CC -!- TISSUE SPECIFICITY: Expressed in spleen, thymus, colon and peripheral CC blood lymphocytes. Detected in myeloid and B-lymphoid cell lines. CC Isoform 2 and isoform 3 are expressed in malignant Hodgkin lymphoma CC cells called Hodgkin and Reed-Sternberg (HRS) cells. CC {ECO:0000269|PubMed:12824192, ECO:0000269|PubMed:9862343}. CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:9862343}. CC -!- MISCELLANEOUS: Isoform 2 and isoform 3 are produced in HRS cells by a CC transcriptional control mechanism which cotranscribe an mRNA containing CC LY75 and CD302 prior to generating the intergenically spliced mRNA to CC produce LY75/CD302 fusion proteins. CC -!- MISCELLANEOUS: [Isoform 2]: Produced by intergenic splicing of LY75 and CC CD302. {ECO:0000305}. CC -!- MISCELLANEOUS: [Isoform 3]: Produced by intergenic splicing of LY75 and CC CD302. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding; CC Note=DEC-205; CC URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_250"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF064827; AAC62622.1; -; mRNA. DR EMBL; AF011333; AAC17636.1; -; mRNA. DR EMBL; AY184222; AAN85434.1; -; mRNA. DR EMBL; AY314006; AAP79899.1; -; mRNA. DR EMBL; AC009961; AAY14943.1; -; Genomic_DNA. DR EMBL; AC093873; AAY24189.1; -; Genomic_DNA. DR CCDS; CCDS2211.1; -. [O60449-1] DR RefSeq; NP_001185688.1; NM_001198759.1. [O60449-2] DR RefSeq; NP_001185689.1; NM_001198760.1. [O60449-3] DR RefSeq; NP_002340.2; NM_002349.3. [O60449-1] DR PDB; 7JPT; EM; 3.20 A; A=30-1722. DR PDB; 7JPU; EM; 5.00 A; A/B/C/D=1-1722. DR PDB; 8HBC; X-ray; 3.35 A; A/B=31-627. DR PDB; 8K8H; X-ray; 2.79 A; A=32-627. DR PDBsum; 7JPT; -. DR PDBsum; 7JPU; -. DR PDBsum; 8HBC; -. DR PDBsum; 8K8H; -. DR AlphaFoldDB; O60449; -. DR EMDB; EMD-22422; -. DR EMDB; EMD-22423; -. DR EMDB; EMD-6333; -. DR SMR; O60449; -. DR IntAct; O60449; 4. DR STRING; 9606.ENSP00000263636; -. DR ChEMBL; CHEMBL4804258; -. DR CarbonylDB; O60449; -. DR GlyConnect; 1472; 1 N-Linked glycan (1 site). DR GlyCosmos; O60449; 16 sites, 2 glycans. DR GlyGen; O60449; 21 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site). DR iPTMnet; O60449; -. DR PhosphoSitePlus; O60449; -. DR BioMuta; LY75; -. DR jPOST; O60449; -. DR MassIVE; O60449; -. DR PaxDb; 9606-ENSP00000263636; -. DR PeptideAtlas; O60449; -. DR ProteomicsDB; 49406; -. [O60449-1] DR ProteomicsDB; 49407; -. [O60449-2] DR ProteomicsDB; 49408; -. [O60449-3] DR ABCD; O60449; 1 sequenced antibody. DR Antibodypedia; 3669; 606 antibodies from 41 providers. DR CPTC; O60449; 1 antibody. DR DNASU; 4065; -. DR Ensembl; ENST00000263636.5; ENSP00000263636.4; ENSG00000054219.11. [O60449-1] DR GeneID; 100526664; -. DR GeneID; 4065; -. DR KEGG; hsa:100526664; -. DR KEGG; hsa:4065; -. DR MANE-Select; ENST00000263636.5; ENSP00000263636.4; NM_002349.4; NP_002340.2. DR UCSC; uc002ubc.6; human. [O60449-1] DR AGR; HGNC:38828; -. DR AGR; HGNC:6729; -. DR CTD; 100526664; -. DR CTD; 4065; -. DR DisGeNET; 100526664; -. DR DisGeNET; 4065; -. DR GeneCards; LY75; -. DR HGNC; HGNC:6729; LY75. DR HPA; ENSG00000054219; Tissue enriched (lymphoid). DR MIM; 604524; gene. DR neXtProt; NX_O60449; -. DR OpenTargets; ENSG00000054219; -. DR OpenTargets; ENSG00000248672; -. DR PharmGKB; PA30493; -. DR VEuPathDB; HostDB:ENSG00000054219; -. DR eggNOG; KOG4297; Eukaryota. DR GeneTree; ENSGT01050000244842; -. DR HOGENOM; CLU_002069_2_0_1; -. DR InParanoid; O60449; -. DR OMA; RMENIHC; -. DR OrthoDB; 4271106at2759; -. DR PhylomeDB; O60449; -. DR TreeFam; TF316663; -. DR PathwayCommons; O60449; -. DR SignaLink; O60449; -. DR BioGRID-ORCS; 100526664; 32 hits in 667 CRISPR screens. DR BioGRID-ORCS; 4065; 13 hits in 1094 CRISPR screens. DR GeneWiki; LY75; -. DR Pharos; O60449; Tbio. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; O60449; protein. DR Bgee; ENSG00000054219; Expressed in thymus and 166 other cell types or tissues. DR GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0005886; C:plasma membrane; TAS:ProtInc. DR GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW. DR GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central. DR GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW. DR GO; GO:0006955; P:immune response; TAS:ProtInc. DR GO; GO:0006954; P:inflammatory response; TAS:ProtInc. DR CDD; cd00037; CLECT; 10. DR CDD; cd00062; FN2; 1. DR CDD; cd00161; RICIN; 1. DR Gene3D; 2.80.10.50; -; 1. DR Gene3D; 2.10.10.10; Fibronectin, type II, collagen-binding; 1. DR Gene3D; 3.10.100.10; Mannose-Binding Protein A, subunit A; 10. DR InterPro; IPR001304; C-type_lectin-like. DR InterPro; IPR016186; C-type_lectin-like/link_sf. DR InterPro; IPR050111; C-type_lectin/snaclec_domain. DR InterPro; IPR018378; C-type_lectin_CS. DR InterPro; IPR016187; CTDL_fold. DR InterPro; IPR000562; FN_type2_dom. DR InterPro; IPR036943; FN_type2_sf. DR InterPro; IPR013806; Kringle-like. DR InterPro; IPR035992; Ricin_B-like_lectins. DR InterPro; IPR000772; Ricin_B_lectin. DR PANTHER; PTHR22803:SF65; LYMPHOCYTE ANTIGEN 75; 1. DR PANTHER; PTHR22803; MANNOSE, PHOSPHOLIPASE, LECTIN RECEPTOR RELATED; 1. DR Pfam; PF00040; fn2; 1. DR Pfam; PF00059; Lectin_C; 10. DR SMART; SM00034; CLECT; 10. DR SMART; SM00059; FN2; 1. DR SMART; SM00458; RICIN; 1. DR SUPFAM; SSF56436; C-type lectin-like; 10. DR SUPFAM; SSF57440; Kringle-like; 1. DR SUPFAM; SSF50370; Ricin B-like lectins; 1. DR PROSITE; PS00615; C_TYPE_LECTIN_1; 1. DR PROSITE; PS50041; C_TYPE_LECTIN_2; 10. DR PROSITE; PS00023; FN2_1; 1. DR PROSITE; PS51092; FN2_2; 1. DR PROSITE; PS50231; RICIN_B_LECTIN; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Direct protein sequencing; KW Disulfide bond; Endocytosis; Glycoprotein; Lectin; Membrane; KW Phosphoprotein; Proteomics identification; Receptor; Reference proteome; KW Repeat; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..27 FT /evidence="ECO:0000269|PubMed:9862343" FT CHAIN 28..1722 FT /note="Lymphocyte antigen 75" FT /id="PRO_0000017552" FT TOPO_DOM 28..1666 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1667..1691 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1692..1722 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 33..156 FT /note="Ricin B-type lectin" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00174" FT DOMAIN 164..211 FT /note="Fibronectin type-II" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00479" FT DOMAIN 225..341 FT /note="C-type lectin 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 368..486 FT /note="C-type lectin 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 493..625 FT /note="C-type lectin 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 652..778 FT /note="C-type lectin 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 818..931 FT /note="C-type lectin 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 958..1091 FT /note="C-type lectin 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 1110..1222 FT /note="C-type lectin 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 1251..1374 FT /note="C-type lectin 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 1401..1513 FT /note="C-type lectin 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT DOMAIN 1542..1661 FT /note="C-type lectin 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00040" FT MOD_RES 933 FT /note="Phosphotyrosine" FT /evidence="ECO:0007744|PubMed:18669648" FT MOD_RES 1703 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q60767" FT MOD_RES 1719 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q60767" FT CARBOHYD 135 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 345 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 377 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 529 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 843 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 865 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 934 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1076 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1103 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1225 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1320 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1392 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1593 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1626 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 169..194 FT /evidence="ECO:0000250" FT DISULFID 183..209 FT /evidence="ECO:0000250" FT DISULFID 247..340 FT /evidence="ECO:0000250" FT DISULFID 317..332 FT /evidence="ECO:0000250" FT DISULFID 389..485 FT /evidence="ECO:0000250" FT DISULFID 462..477 FT /evidence="ECO:0000250" FT DISULFID 597..614 FT /evidence="ECO:0000250" FT DISULFID 840..930 FT /evidence="ECO:0000250" FT DISULFID 904..922 FT /evidence="ECO:0000250" FT DISULFID 1060..1080 FT /evidence="ECO:0000250" FT DISULFID 1197..1211 FT /evidence="ECO:0000250" FT DISULFID 1488..1502 FT /evidence="ECO:0000250" FT DISULFID 1635..1650 FT /evidence="ECO:0000250" FT VAR_SEQ 1608..1722 FT /note="DQSWSWLDGSEVTFVKWENKSKSGVGRCSMLIASNETWKKVECEHGFGRVVC FT KVPLGPDYTAIAIIVATLSILVLMGGLIWFLFQRHRLHLAGFSSVRYAQGVNEDEIMLP FT SFHD -> DCPSSTWIQFQDSCYIFLQEAIKVESIEDVRNQCTDHGADMISIHNEEENA FT FILDTLKKQWKGPDDILLGMFYDTDDASFKWFDNSNMTFDKWTDQDDDEDLVDTCAFLH FT IKTGEWKKGNCEVSSVEGTLCKTAIPYKRKYLSDNHILISALVIASTVILTVLGAIIWF FT LYKKHSDSRFTTVFSTAPQSPYNEDCVLVVGEENEYPVQFD (in isoform 3)" FT /evidence="ECO:0000303|PubMed:12824192" FT /id="VSP_020908" FT VAR_SEQ 1664..1722 FT /note="GPDYTAIAIIVATLSILVLMGGLIWFLFQRHRLHLAGFSSVRYAQGVNEDEI FT MLPSFHD -> DCPSSTWIQFQDSCYIFLQEAIKVESIEDVRNQCTDHGADMISIHNEE FT ENAFILDTLKKQWKGPDDILLGMFYDTDDASFKWFDNSNMTFDKWTDQDDDEDLVDTCA FT FLHIKTGEWKKGNCEVSSVEGTLCKTAIPYKRKYLSDNHILISALVIASTVILTVLGAI FT IWFLYKKHSDSRFTTVFSTAPQSPYNEDCVLVVGEENEYPVQFD (in isoform FT 2)" FT /evidence="ECO:0000303|PubMed:12824192" FT /id="VSP_020909" FT VARIANT 20 FT /note="W -> R (in dbSNP:rs35284483)" FT /id="VAR_056156" FT VARIANT 268 FT /note="E -> D (in dbSNP:rs2271381)" FT /evidence="ECO:0000269|PubMed:9862343" FT /id="VAR_027824" FT VARIANT 486 FT /note="K -> M (in dbSNP:rs2729709)" FT /id="VAR_027825" FT VARIANT 666 FT /note="V -> A (in dbSNP:rs34020639)" FT /id="VAR_056157" FT VARIANT 692 FT /note="D -> N (in dbSNP:rs1397706)" FT /id="VAR_024522" FT VARIANT 807 FT /note="D -> E (in dbSNP:rs3951216)" FT /evidence="ECO:0000269|PubMed:9862343" FT /id="VAR_027826" FT VARIANT 884 FT /note="D -> A (in dbSNP:rs3815875)" FT /id="VAR_027827" FT VARIANT 1202 FT /note="T -> S (in dbSNP:rs2303549)" FT /id="VAR_027828" FT VARIANT 1321 FT /note="K -> N (in dbSNP:rs12692566)" FT /evidence="ECO:0000269|PubMed:12824192, FT ECO:0000269|PubMed:9553150" FT /id="VAR_027829" FT VARIANT 1347 FT /note="K -> R (in dbSNP:rs17827158)" FT /id="VAR_027830" FT VARIANT 1391 FT /note="Y -> H (in dbSNP:rs2059696)" FT /id="VAR_027831" FT VARIANT 1393 FT /note="T -> I (in dbSNP:rs35941588)" FT /id="VAR_056158" FT STRAND 38..43 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 46..50 FT /evidence="ECO:0007829|PDB:8HBC" FT STRAND 51..54 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 62..64 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 67..70 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 71..73 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 74..77 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 78..80 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 83..85 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 96..98 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 100..102 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 103..105 FT /evidence="ECO:0007829|PDB:8HBC" FT STRAND 109..111 FT /evidence="ECO:0007829|PDB:8HBC" FT STRAND 112..114 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 118..120 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 122..126 FT /evidence="ECO:0007829|PDB:8HBC" FT STRAND 129..131 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 140..142 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 159..166 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 173..175 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 178..180 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 187..195 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 200..203 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 206..209 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 214..217 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 220..222 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 227..238 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 240..249 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 260..267 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 274..276 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 284..286 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 292..294 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 310..313 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 319..321 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 322..325 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 326..328 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 336..343 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 362..368 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 371..380 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 383..390 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 391..393 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 402..410 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 412..416 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 421..427 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 429..433 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 435..438 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 461..466 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 467..470 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 471..475 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 481..488 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 503..505 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 506..508 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 511..513 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 515..517 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 535..548 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 550..553 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 556..561 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 566..568 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 574..576 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 593..595 FT /evidence="ECO:0007829|PDB:8HBC" FT STRAND 597..600 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 603..605 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 609..612 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 614..616 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 622..625 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 629..632 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 644..646 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 653..660 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 662..664 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 671..680 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 691..701 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 711..716 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 720..722 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 745..749 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 752..755 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 769..772 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 780..788 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 793..796 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 797..799 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 800..804 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 805..812 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 823..831 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 833..840 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 842..847 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 853..866 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 872..874 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 907..911 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 912..916 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 926..932 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 945..948 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 956..958 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 961..964 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 970..972 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 973..982 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 983..987 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 993..1002 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1003..1005 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1008..1010 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1015..1020 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 1025..1027 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 1038..1040 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1058..1064 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 1070..1073 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1075..1078 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1082..1085 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1089..1091 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1108..1110 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1113..1118 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1124..1133 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1144..1157 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1164..1167 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1169..1172 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1174..1176 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1187..1189 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1195..1200 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1206..1209 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1211..1213 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1218..1222 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1269..1280 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1281..1283 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1293..1303 FT /evidence="ECO:0007829|PDB:7JPT" FT TURN 1304..1308 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1310..1313 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1319..1321 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1324..1328 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1336..1339 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1348..1352 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1358..1362 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1366..1368 FT /evidence="ECO:0007829|PDB:7JPT" FT HELIX 1370..1374 FT /evidence="ECO:0007829|PDB:7JPT" FT STRAND 1376..1379 FT /evidence="ECO:0007829|PDB:7JPT" SQ SEQUENCE 1722 AA; 198311 MW; 4BC17EC646BF016F CRC64; MRTGWATPRR PAGLLMLLFW FFDLAEPSGR AANDPFTIVH GNTGKCIKPV YGWIVADDCD ETEDKLWKWV SQHRLFHLHS QKCLGLDITK SVNELRMFSC DSSAMLWWKC EHHSLYGAAR YRLALKDGHG TAISNASDVW KKGGSEESLC DQPYHEIYTR DGNSYGRPCE FPFLIDGTWH HDCILDEDHS GPWCATTLNY EYDRKWGICL KPENGCEDNW EKNEQFGSCY QFNTQTALSW KEAYVSCQNQ GADLLSINSA AELTYLKEKE GIAKIFWIGL NQLYSARGWE WSDHKPLNFL NWDPDRPSAP TIGGSSCARM DAESGLWQSF SCEAQLPYVC RKPLNNTVEL TDVWTYSDTR CDAGWLPNNG FCYLLVNESN SWDKAHAKCK AFSSDLISIH SLADVEVVVT KLHNEDIKEE VWIGLKNINI PTLFQWSDGT EVTLTYWDEN EPNVPYNKTP NCVSYLGELG QWKVQSCEEK LKYVCKRKGE KLNDASSDKM CPPDEGWKRH GETCYKIYED EVPFGTNCNL TITSRFEQEY LNDLMKKYDK SLRKYFWTGL RDVDSCGEYN WATVGGRRRA VTFSNWNFLE PASPGGCVAM STGKSVGKWE VKDCRSFKAL SICKKMSGPL GPEEASPKPD DPCPEGWQSF PASLSCYKVF HAERIVRKRN WEEAERFCQA LGAHLSSFSH VDEIKEFLHF LTDQFSGQHW LWIGLNKRSP DLQGSWQWSD RTPVSTIIMP NEFQQDYDIR DCAAVKVFHR PWRRGWHFYD DREFIYLRPF ACDTKLEWVC QIPKGRTPKT PDWYNPDRAG IHGPPLIIEG SEYWFVADLH LNYEEAVLYC ASNHSFLATI TSFVGLKAIK NKIANISGDG QKWWIRISEW PIDDHFTYSR YPWHRFPVTF GEECLYMSAK TWLIDLGKPT DCSTKLPFIC EKYNVSSLEK YSPDSAAKVQ CSEQWIPFQN KCFLKIKPVS LTFSQASDTC HSYGGTLPSV LSQIEQDFIT SLLPDMEATL WIGLRWTAYE KINKWTDNRE LTYSNFHPLL VSGRLRIPEN FFEEESRYHC ALILNLQKSP FTGTWNFTSC SERHFVSLCQ KYSEVKSRQT LQNASETVKY LNNLYKIIPK TLTWHSAKRE CLKSNMQLVS ITDPYQQAFL SVQALLHNSS LWIGLFSQDD ELNFGWSDGK RLHFSRWAET NGQLEDCVVL DTDGFWKTVD CNDNQPGAIC YYSGNETEKE VKPVDSVKCP SPVLNTPWIP FQNCCYNFII TKNRHMATTQ DEVHTKCQKL NPKSHILSIR DEKENNFVLE QLLYFNYMAS WVMLGITYRN KSLMWFDKTP LSYTHWRAGR PTIKNEKFLA GLSTDGFWDI QTFKVIEEAV YFHQHSILAC KIEMVDYKEE YNTTLPQFMP YEDGIYSVIQ KKVTWYEALN MCSQSGGHLA SVHNQNGQLF LEDIVKRDGF PLWVGLSSHD GSESSFEWSD GSTFDYIPWK GQTSPGNCVL LDPKGTWKHE KCNSVKDGAI CYKPTKSKKL SRLTYSSRCP AAKENGSRWI QYKGHCYKSD QALHSFSEAK KLCSKHDHSA TIVSIKDEDE NKFVSRLMRE NNNITMRVWL GLSQHSVDQS WSWLDGSEVT FVKWENKSKS GVGRCSMLIA SNETWKKVEC EHGFGRVVCK VPLGPDYTAI AIIVATLSIL VLMGGLIWFL FQRHRLHLAG FSSVRYAQGV NEDEIMLPSF HD //